1
Pisters, R., van Vugt, S. P. G., Brouwer, M. A., Elvan, A., ten Holt, W. L., Zwart, P. A. G., Kirchhof, P., Crijns, H. J. G. M., Hemels, M. E. W.
Veröffentlicht in: Pisters , R , van Vugt , S P G , Brouwer , M A , Elvan , A , ten Holt , W L , Zwart , P A G , Kirchhof , P , Crijns , H J G M & Hemels , M E W 2017 , ' Real-life use of Rivaroxaban in the Netherlands : data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry ' , Netherlands Heart Journal , vol. 25 , no. 10 , pp. 551-558 . https://doi.org/10.1007/s12471-017-1009-9;
2017
Veröffentlicht in: Pisters , R , van Vugt , S P G , Brouwer , M A , Elvan , A , ten Holt , W L , Zwart , P A G , Kirchhof , P , Crijns , H J G M & Hemels , M E W 2017 , ' Real-life use of Rivaroxaban in the Netherlands : data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry ' , Netherlands Heart Journal , vol. 25 , no. 10 , pp. 551-558 . https://doi.org/10.1007/s12471-017-1009-9;
2017